Wash-in Period in Patients Undergoing Low Flow Anesthesia

NCT ID: NCT06967948

Last Updated: 2025-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-10

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Volunteers above the age of 18 and below the age of 60 who agreed to participate in the study were not exposed to any interventional intervention other than those routinely applied to the patient during and after the administration of the clinical standard anesthesia protocol. The value indicating the brain's response to hypnotic substances, the vapor concentration in the lung alveoli and the minimum amount of anesthesia gas used will be recorded at certain times. The aim of the researchers in the study was to observe the effect of two different fresh gas flow rates on the amount and cost of waste gas released into the atmosphere.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anesthetic management of a patient receiving general anesthesia consists of induction, maintenance and termination periods. In the "wash in period" (saturation of the circuit between the anesthesia device and the patient), high fresh gas flows, usually 2-4 l/min fresh gas flow (50% oxygen and 50% air/nitrous oxide mixture) are used. Inhaled anesthetic agents are routinely used in resuscitation. However, the part of this inhaled agent that is not used by the patient is released into the atmosphere and environment. The higher the flow of fresh gas administered, the greater the proportion not used by the patient and discharged into the atmosphere. These waste gases contribute significantly to the greenhouse effect in the atmosphere. Occupational exposure (liver-kidney disease, neurologic disease, cancer, spontaneous abortions, etc. in healthcare workers) accounts for the portion released into the environment. The consumption and cost of inhalation agents depends on the fresh gas flow rate, vaporizer setting and duration of anesthesia. It has been observed that reducing the fresh gas flow rate significantly reduces the cost. The aim of the researchers in the study was to observe the effect of a fresh gas flow rate of 1 l/min to 4 l/min on the amount of waste gas discharged into the atmosphere and thus on the cost of inhaled agents.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inhalation Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 lt/min

''Wash in period'' 1 lt/min fresh gas flow is used.

No interventions assigned to this group

4 lt/min

''Wash in period'' 4 lt/min fresh gas flow is used.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA I-II risk group patients Duration of surgery between 2 hours and 4 hours, cases with general anesthesia

Exclusion Criteria

* Patient refusal to participate in the study
* Under 18 years old BMI\>40
* Patients receiving invasive mechanical ventilator support in the last 1 month
* Patients who have received chemotherapy or radiotherapy in the last 2 months
* Those with severe lung disease (COPD, asthma, pulmonary infection, bronchiectasis, previous need for non-invasive mechanical ventilation, oxygen therapy or steroid therapy for acute attack)
* Known severe pulmonary hypertension
* Smoke poisoning (carbon monoxide, cyanide poisoning)
* Alcohol or acetone poisoning
* Malignant hyperthermia
* Intracranial tumor
* Hemodynamic instability
* Shock
* Neuromuscular disease
* Pathologies causing increased intracranial and intraocular pressure
* Those with severe cardiac arrhythmias Those with -EF\<30
* Severe peripheral arterial disease
* Patients with liver and kidney dysfunction
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Serkan Uckun

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Serkan Uckun

assistant professor

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Balıkesir University Health Practice and Research Hospital Operating Room

Balıkesir, , Turkey (Türkiye)

Site Status RECRUITING

Balıkesir University Health Practice and Research Hospital

Balıkesir, , Turkey (Türkiye)

Site Status RECRUITING

Balıkesir University Health Practice and Research Hospital

Balıkesir, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Serkan Uçkun, assistant professor

Role: CONTACT

+90 535 370 11 64

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Serkan Uçkun, Assistant professor

Role: primary

+905353701164

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SUckun

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Minimal Flow Anesthesia and Infection Risk
NCT07092046 ACTIVE_NOT_RECRUITING NA